(Q35055517)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24283428%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

title

Clinical course and risk factors of neurotoxicity following cisplatin in an intensive dosing schedule (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24283428%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

1 reference

1 reference

1 reference

Martin J van den Bent

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24283428%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

author name string

P H Hilkens

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24283428%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

A S Planting

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24283428%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

M E van der Burg

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24283428%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

J W Moll

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24283428%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

W L van Putten

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24283428%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

C J Vecht

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24283428%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

publication date

1 September 1994

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24283428%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Neurology

1 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24283428%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

volume

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24283428%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24283428%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

page(s)

45-50

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24283428%20AND%20SRC:MED&resulttype=core&format=json

High-dose platinum for the treatment of refractory ovarian cancer

1 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.1994.TB00049.X

Cisplatin dose intensity in non-small cell lung cancer: phase II results of a day 1 and day 8 high-dose regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.1994.TB00049.X

Incidence of neuropathy in 395 patients with ovarian cancer treated with or without cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.1994.TB00049.X

Prevention of cisplatin neurotoxicity with an ACTH(4-9) analogue in patients with ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.1994.TB00049.X

Standardised method of determining vibratory perception thresholds for diagnosis and screening in neurological investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.1994.TB00049.X

Progressive paresthesias after cessation of therapy with very high-dose cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.1994.TB00049.X

Evolution of high-dose cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.1994.TB00049.X

The course of neuropathy after cessation of cisplatin treatment, combined with Org 2766 or placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.1994.TB00049.X

Large and small fibre type sensory dysfunction in patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.1994.TB00049.X

Cisplatin neuropathy. Risk factors, prognosis, and protection by WR-2721.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.1994.TB00049.X

Unusual presentation of cis-platinum neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.1994.TB00049.X

High-dose cisplatin therapy for cancer of the ovary: neurotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.1994.TB00049.X

Phase I/II study of a short course of weekly cisplatin in patients with advanced solid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.1994.TB00049.X

Peripheral sensory neuropathy and cisplatin chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.1994.TB00049.X

Cisplatin neuropathy. Clinical, electrophysiologic, morphologic, and toxicologic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.1994.TB00049.X

The effects of an ACTH (4-9) analogue on development of cisplatin neuropathy in testicular cancer: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.1994.TB00049.X

Examination of distal involvement in cisplatin-induced neuropathy in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.1994.TB00049.X

The incidence and course of paraneoplastic neuropathy in women with epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.1994.TB00049.X

10.1111/J.1468-1331.1994.TB00049.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24283428%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

1 reference